CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced that the company has entered exclusive agreements with key distributors to supply the INTERCEPT Blood System for platelet and plasma in Chile, Indonesia and Poland. These new distributor relationships broaden the company’s access to markets for the INTERCEPT Blood System, which is already marketed in over 30 countries in Europe, Asia and the Middle East.
